Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KOS
|
Warburg Pincus & Co.
Director |
SELL
Open market or private sale
|
Direct | 26,504,790 Reduced 90.1% |
$172,546,189
$6.51 p/Share
|
Mar 01
2019 |
|
DNP
|
American International Group, Inc. |
SELL
Other acquisition or disposition
|
Indirect | 1,000 Reduced 100.0% |
$100,000,000
$100000.0 p/Share
|
Mar 01
2019 |
|
PTC
|
Donald K Grierson |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 9.66% |
$467,350
$93.47 p/Share
|
Mar 01
2019 |
|
HAIN
|
Welling Glenn W.
Director |
BUY
Open market or private purchase
|
Indirect | 389,290 Added 13.45% |
$7,552,226
$19.4 p/Share
|
Mar 01
2019 |
|
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,664 Added 16.28% |
$74,996
$45.07 p/Share
|
Mar 01
2019 |
|
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
SELL
Open market or private sale
|
Direct | 1,664 Reduced 19.45% |
$96,745
$58.14 p/Share
|
Mar 01
2019 |
|
WMT
|
S Robson Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 694,483 Reduced 1.28% |
$68,573,250
$98.74 p/Share
|
Mar 01
2019 |
|
WMT
|
Alice L Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 694,483 Reduced 1.28% |
$68,573,250
$98.74 p/Share
|
Mar 01
2019 |
|
WMT
|
Jim C Walton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 694,483 Reduced 1.28% |
$68,573,250
$98.74 p/Share
|
Mar 01
2019 |
|
FAF
|
Kenneth D Degiorgio
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,052 Reduced 1.57% |
$360,145
$51.07 p/Share
|
Feb 28
2019 |
|
SIVB
|
John China
President of SVB Capital |
SELL
Open market or private sale
|
Direct | 11,200 Reduced 38.93% |
$2,790,144
$249.12 p/Share
|
Feb 28
2019 |
|
SIVB
|
John China
President of SVB Capital |
BUY
Exercise of conversion of derivative security
|
Direct | 11,200 Added 28.02% |
$758,688
$67.74 p/Share
|
Feb 28
2019 |
|
WST
|
Patrick J Zenner |
BUY
Open market or private purchase
|
Direct | 54 Added 0.08% |
$5,678
$105.14 p/Share
|
Feb 28
2019 |
|
JNJ
|
Michael H Ullmann
Exec VP, General Counsel |
SELL
Bona fide gift
|
Direct | 736 Reduced 0.55% |
-
|
Feb 28
2019 |
|
BRK-A
|
Buffett Warren E
Chairman and CEO |
SELL
Bona fide gift
|
Direct | 24,765 Reduced 21.36% |
-
|
Feb 28
2019 |
|
AROW
|
Raymond F O'Conor
Director |
SELL
Bona fide gift
|
Direct | 200 Reduced 0.45% |
-
|
Feb 28
2019 |
|
JEF
|
Richard B Handler
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 71,425 Added 0.44% |
$1,447,785
$20.27 p/Share
|
Feb 28
2019 |
|
JEF
|
Brian P Friedman
President |
BUY
Grant, award, or other acquisition
|
Direct | 31,118 Added 0.37% |
$630,762
$20.27 p/Share
|
Feb 28
2019 |
|
JEF
|
Michael T O Kane |
BUY
Grant, award, or other acquisition
|
Direct | 331 Added 0.52% |
$6,709
$20.27 p/Share
|
Feb 28
2019 |
|
JEF
|
Robert Eugene Joyal |
BUY
Grant, award, or other acquisition
|
Direct | 327 Added 0.43% |
$6,628
$20.27 p/Share
|
Feb 28
2019 |
|
AFGR
|
Elliott Associates, L.P.
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 659,965 Added 45.33% |
$6,600
$0.01 p/Share
|
Feb 28
2019 |
|
AFGR
|
Elliott International, L.P.
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 1,402,426 Added 45.33% |
$14,024
$0.01 p/Share
|
Feb 28
2019 |
|
NWBI
|
Shawn O Walker
EVP, Marketing Communications |
SELL
Open market or private sale
|
Direct | 1,780 Reduced 5.03% |
$33,250
$18.68 p/Share
|
Feb 28
2019 |
|
NWBI
|
Shawn O Walker
EVP, Marketing Communications |
BUY
Exercise of conversion of derivative security
|
Direct | 1,780 Added 4.79% |
$23,407
$13.15 p/Share
|
Feb 28
2019 |
|
NWBI
|
Steven G Fisher
SEVP Chief Innovation Officer |
SELL
Open market or private sale
|
Direct | 35,205 Reduced 17.85% |
$657,981
$18.69 p/Share
|
Feb 28
2019 |
|
NWBI
|
Steven G Fisher
SEVP Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 35,205 Added 15.15% |
$421,756
$11.98 p/Share
|
Feb 28
2019 |
|
AFGR
|
Empyrean Capital Partners, LP
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 611,002 Added 24.55% |
$6,110
$0.01 p/Share
|
Feb 28
2019 |
|
NMRK
|
Stephen M Merkel
Chairman of the Board & CLO |
BUY
Grant, award, or other acquisition
|
Direct | 42,864 Added 43.71% |
-
|
Feb 28
2019 |
|
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 12,398 Added 0.26% |
$9,918
$0.8 p/Share
|
Feb 28
2019 |
|
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 5,899 Added 0.29% |
$4,719
$0.8 p/Share
|
Feb 28
2019 |
|
IVZ
|
Kevin M Carome
SMD and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 21,528 Reduced 3.97% |
$416,567
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Kevin M Carome
SMD and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 56,919 Added 9.5% |
-
|
Feb 28
2019 |
|
IVZ
|
Mark F Giuliano
SMD & Chief Adm Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,219 Reduced 2.58% |
$23,588
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Mark F Giuliano
SMD & Chief Adm Officer |
BUY
Grant, award, or other acquisition
|
Direct | 31,240 Added 39.78% |
-
|
Feb 28
2019 |
|
IVZ
|
Martin L Flanagan
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 275,394 Added 29.0% |
-
|
Feb 28
2019 |
|
IVZ
|
Annette Lege
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,165 Reduced 4.08% |
$61,243
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Annette Lege
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19,699 Added 20.26% |
-
|
Feb 28
2019 |
|
IVZ
|
Gregory Mc Greevey
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 27,634 Reduced 5.98% |
$534,718
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Gregory Mc Greevey
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 71,043 Added 13.33% |
-
|
Feb 28
2019 |
|
IVZ
|
Colin Meadows
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 30,810 Reduced 11.06% |
$596,174
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Colin Meadows
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 84,090 Added 23.18% |
-
|
Feb 28
2019 |
|
IVZ
|
Loren M Starr
SMD & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 27,487 Reduced 4.47% |
$531,873
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Loren M Starr
SMD & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 75,445 Added 10.93% |
-
|
Feb 28
2019 |
|
IVZ
|
Andrew Tak Shing Lo
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 27,124 Added 5.55% |
-
|
Feb 28
2019 |
|
IVZ
|
Andrew Tak Shing Lo
Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct | 47,970 Added 9.03% |
-
|
Feb 28
2019 |
|
IVZ
|
Andrew Schlossberg
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,024 Reduced 5.0% |
$155,264
$19.35 p/Share
|
Feb 28
2019 |
|
IVZ
|
Philip Taylor
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 11,050 Added 3.98% |
-
|
Feb 28
2019 |
|
IVZ
|
Philip Taylor
Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct | 54,216 Added 15.19% |
-
|
Feb 28
2019 |
|
IVZ
|
Philip Taylor
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 32,927 Reduced 10.88% |
$637,137
$19.35 p/Share
|
Feb 28
2019 |
|
WTM
|
Jess Brian Palmer
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 500 Added 24.27% |
-
|
Feb 28
2019 |